Patents Assigned to B&A ONCOMEDICAL
  • COMBINATION OF COMPOUNDS FOR USE IN THERAPY
    Publication number: 20240033238
    Abstract: The present invention relates to a combination of compounds for a use in therapy and especially to a therapeutic combination for use in the treatment of tumours and/or cancer. In particular, the invention relates to a therapeutic combination that comprises a NKCC1 protein inhibitor and a microtubule inhibitor, optionally together with one or more additional chemotherapeutic agents or radiotherapy. The combined administration includes at least one NKCC1 protein inhibitor and at least one microtubule inhibitor.
    Type: Application
    Filed: July 28, 2023
    Publication date: February 1, 2024
    Applicant: B&A ONCOMEDICAL
    Inventors: Yehezkel BEN-ARI, François BERGER